SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013058
Filing Date
2023-08-03
Accepted
2023-08-03 07:15:33
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20230630x10q.htm   iXBRL 10-Q 1679919
2 EX-31.1 vygr-20230630xex31d1.htm EX-31.1 13687
3 EX-31.2 vygr-20230630xex31d2.htm EX-31.2 13778
4 EX-32.1 vygr-20230630xex32d1.htm EX-32.1 10718
5 GRAPHIC vygr-20230630x10q006.jpg GRAPHIC 100744
  Complete submission text file 0001558370-23-013058.txt   7183702

Data Files

Seq Description Document Type Size
6 EX-101.SCH vygr-20230630.xsd EX-101.SCH 48081
7 EX-101.CAL vygr-20230630_cal.xml EX-101.CAL 46999
8 EX-101.DEF vygr-20230630_def.xml EX-101.DEF 193282
9 EX-101.LAB vygr-20230630_lab.xml EX-101.LAB 394369
10 EX-101.PRE vygr-20230630_pre.xml EX-101.PRE 309597
56 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20230630x10q_htm.xml XML 1292653
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 231138043
SIC: 2836 Biological Products, (No Diagnostic Substances)